000 | 00991 a2200301 4500 | ||
---|---|---|---|
005 | 20250516122506.0 | ||
264 | 0 | _c20130827 | |
008 | 201308s 0 0 eng d | ||
022 | _a1949-2553 | ||
024 | 7 |
_a10.18632/oncotarget.735 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMcCormack, William | |
245 | 0 | 0 |
_aToll-like receptor 2: therapeutic target for gastric carcinogenesis. _h[electronic resource] |
260 |
_bOncotarget _cNov 2012 |
||
300 |
_a1260-1 p. _bdigital |
||
500 | _aPublication Type: Editorial | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 |
_aStomach Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aToll-Like Receptor 2 _xantagonists & inhibitors |
700 | 1 | _aOshima, Masanobu | |
700 | 1 | _aTan, Patrick | |
700 | 1 | _aJenkins, Brendan | |
773 | 0 |
_tOncotarget _gvol. 3 _gno. 11 _gp. 1260-1 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.735 _zAvailable from publisher's website |
999 |
_c22285929 _d22285929 |